Paulson & Co.
The book · Q2 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q2 |
|---|---|---|---|---|---|---|
| 1 | MDGL | MADRIGAL PHARMACEUTICALS INC | 1.34M | $720M | 27.9% | −4% |
| 2 | PPTA | PERPETUA RESOURCES CORP | 32.35M | $672M | 26.1% | ±0% |
| 3 | AAMI | ACADIAN ASSET MANAGEMENT INC | 5.84M | $418M | 16.2% | −25% |
| 4 | BHC | BAUSCH HEALTH COS INC | 73.26M | $361M | 14.0% | ±0% |
| 5 | THM | INTERNATIONAL TOWER HILL MIN | 104.49M | $208M | 8.1% | +5% |
| 6 | NG | NOVAGOLD RESOURCES INC | 27.24M | $163M | 6.3% | ±0% |
| 7 | THRY | THRYV HLDGS INC | 8.44M | $33M | 1.3% | ±0% |
| 8 | GOOGL | ALPHABET INC | 5K | $2M | 0.1% | NEW |
Where the money is
AC read
Paulson & Co's 13F for Q2 2026, covering the period ending June 30, 2026, shows a tightly held portfolio of just eight positions across $2.6 billion in reported assets. The filing lands on SEC's EDGAR system 45 to 90 days after the quarter closes, so these holdings reflect where the fund stood four months ago, not its current book. Madrigal Pharmaceuticals is the largest position at $720 million, 27.9 percent of the portfolio, followed closely by Perpetua Resources at $672 million, 26.1 percent. Together those two names account for more than half the fund's reported value. American Shared Hospital Services, listed as AAMI, holds $418 million, 16.2 percent, and Bausch Health, BHC, adds another $361 million, 14.0 percent, meaning four positions make up 84.2 percent of the total.
Read the full dossier →